Clinical Trial Update: Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating IDP-124 Lotion for moderate-to-severe atopic dermatitis in adults and children has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• IDP-124 Lotion (IDP-124 lotion)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2023-05-08